Recently adopted names for antitumoral compounds (August 2012) - Noms d’antitumoraux adoptés récemment (août 2012)

Name (nom)	Code name	Type	Target(s)
Aldoxorubicin	INNO-206	An albumin-binding doxorubicin prodrug	DNA intercalator
Gandotinib	LY2784544	Synthetic small molecule inhibitor	JAK2 kinase
Ilorasertib	ABT-348	Synthetic small molecule inhibitor	Aurora kinases A, B and C
Nesvacumab	REGN910	Monoclonal antibody	Angiopoietin-2
Pidilizumab	CT-011	Monoclonal antibody	human programmed cell death 1 (PCD1)
Rebastinib	DCC-2036	Synthetic small molecule inhibitor	BCR-ABL T315I mutant, FLT3-ITD, TRKA, and TIE2
Tergenpumatucel-L	HAL	Stably transduced human lung cancer cell lines (HAL1, HAL2 and HAL3) expressing the murine αGT gene